Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Foley

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Molecular Cancer Research : MCR|October 15, 2009
Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the boneJennifer L Gilmore, Ryan M Gonterman, Keshav Menon, et al.
BMC Cancer|June 6, 2019
Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumorsAmit Hagar, Zemin Wang, Sachiko Koyama, et al.
Differentiation; Research in Biological Diversity|January 25, 2007
Identification of markers for nipple epidermis: changes in expression during pregnancy and lactationJennifer Eastwood, Carlos Offutt, Keshav Menon, et al.
Gynecologic Oncology|February 27, 2004
Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoterNicholas B Berry, Yong Mee Cho, Maureen A Harrington, et al.
Health and Quality of Life Outcomes|December 29, 2012
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal studyJudith J Stephenson, David M Kern, Sonalee S Agarwal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 15, 2022
Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practiceJohn Foley, Kuangnan Xiong, Tammy Hoyt, et al.
Multiple Sclerosis and Related Disorders|May 17, 2024
Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentrationLesley J Page, Iona F Pay, Edward T Castellana, et al.
Breast Cancer Research and Treatment|September 21, 2007
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cellsJennifer L Gilmore, Jeffrey A Scott, Zhor Bouizar, et al.
Plos One|January 26, 2012
Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat padNicole K Nickerson, Khalid S Mohammad, Jennifer L Gilmore, et al.
Mechanisms of Development|February 15, 2015
Expansion of specialized epidermis induced by hormonal state and mechanical strainHsin-Jung Wu, Teresa Easwaran, Carlos D Offutt, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Molecular Cancer Research : MCR|October 15, 2009
Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the boneJennifer L Gilmore, Ryan M Gonterman, Keshav Menon, et al.
BMC Cancer|June 6, 2019
Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumorsAmit Hagar, Zemin Wang, Sachiko Koyama, et al.
Differentiation; Research in Biological Diversity|January 25, 2007
Identification of markers for nipple epidermis: changes in expression during pregnancy and lactationJennifer Eastwood, Carlos Offutt, Keshav Menon, et al.
Gynecologic Oncology|February 27, 2004
Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoterNicholas B Berry, Yong Mee Cho, Maureen A Harrington, et al.
Health and Quality of Life Outcomes|December 29, 2012
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal studyJudith J Stephenson, David M Kern, Sonalee S Agarwal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 15, 2022
Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practiceJohn Foley, Kuangnan Xiong, Tammy Hoyt, et al.
Multiple Sclerosis and Related Disorders|May 17, 2024
Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentrationLesley J Page, Iona F Pay, Edward T Castellana, et al.
Breast Cancer Research and Treatment|September 21, 2007
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cellsJennifer L Gilmore, Jeffrey A Scott, Zhor Bouizar, et al.
Plos One|January 26, 2012
Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat padNicole K Nickerson, Khalid S Mohammad, Jennifer L Gilmore, et al.
Mechanisms of Development|February 15, 2015
Expansion of specialized epidermis induced by hormonal state and mechanical strainHsin-Jung Wu, Teresa Easwaran, Carlos D Offutt, et al.
Pageof 9